These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33121952)

  • 21. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.
    Sim DS; Jeong MH; Ahn Y; Kim YJ; Chae SC; Hong TJ; Seong IW; Chae JK; Kim CJ; Cho MC; Rha SW; Bae JH; Seung KB; Park SJ;
    Circ Cardiovasc Interv; 2016 Sep; 9(9):. PubMed ID: 27582112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet inhibition to target reperfusion injury trial: Rationale and study design.
    Bulluck H; Chan MHH; Bryant JA; Chai P; Chawla A; Chua TS; Chung YC; Fei G; Ho HH; Ho AFW; Hoe AJ; Imran SS; Lee CH; Lim SH; Liew BW; Yun PLZ; Hock MOE; Paradies V; Roe MT; Teo L; Wong AS; Wong E; Wong PE; Watson T; Chan MY; Tan JW; Hausenloy DJ
    Clin Cardiol; 2019 Jan; 42(1):5-12. PubMed ID: 30421441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined Intrahospital Remote Ischemic Perconditioning and Postconditioning Improves Clinical Outcome in ST-Elevation Myocardial Infarction.
    Stiermaier T; Jensen JO; Rommel KP; de Waha-Thiele S; Fuernau G; Desch S; Thiele H; Eitel I
    Circ Res; 2019 May; 124(10):1482-1491. PubMed ID: 30929570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of Intracoronary and Intravenous Melatonin on Myocardial Salvage Index in Patients with ST-Elevation Myocardial Infarction: a Randomized Placebo Controlled Trial.
    Ekeloef S; Halladin N; Fonnes S; Jensen SE; Zaremba T; Rosenberg J; Jonsson G; Aarøe J; Gasbjerg LS; Rosenkilde MM; Gögenur I
    J Cardiovasc Transl Res; 2017 Dec; 10(5-6):470-479. PubMed ID: 29027116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Liraglutide on Reperfusion Injury in Patients With ST-Segment-Elevation Myocardial Infarction.
    Chen WR; Chen YD; Tian F; Yang N; Cheng LQ; Hu SY; Wang J; Yang JJ; Wang SF; Gu XF
    Circ Cardiovasc Imaging; 2016 Dec; 9(12):. PubMed ID: 27940956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipid Biomarkers in Acute Myocardial Infarction Before and After Percutaneous Coronary Intervention by Lipidomics Analysis.
    Feng L; Yang J; Liu W; Wang Q; Wang H; Shi L; Fu L; Xu Q; Wang B; Li T
    Med Sci Monit; 2018 Jun; 24():4175-4182. PubMed ID: 29913478
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
    Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Danegaptide for primary percutaneous coronary intervention in acute myocardial infarction patients: a phase 2 randomised clinical trial.
    Engstrøm T; Nepper-Christensen L; Helqvist S; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamaki K; Tilsted HH; Steensberg A; Fabricius S; Mouritzen U; Vejlstrup N; Ahtarovski KA; Göransson C; Bertelsen L; Kyhl K; Olivecrona G; Kelbæk H; Lassen JF; Køber L; Lønborg J
    Heart; 2018 Oct; 104(19):1593-1599. PubMed ID: 29602883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Editor's Choice- Pathophysiology and therapy of myocardial ischaemia/reperfusion syndrome.
    Rossello X; Lobo-Gonzalez M; Ibanez B
    Eur Heart J Acute Cardiovasc Care; 2019 Aug; 8(5):443-456. PubMed ID: 31172789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
    Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
    Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reperfusion injury in ST-segment elevation myocardial infarction: the final frontier.
    Ndrepepa G; Colleran R; Kastrati A
    Coron Artery Dis; 2017 May; 28(3):253-262. PubMed ID: 28072597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of late reperfusion in ST-segment elevation myocardial infarction: a real-world retrospective cohort study.
    Guo Q; Huang J; Shen Y; Tong G; Li H; Meng S
    BMC Cardiovasc Disord; 2020 Apr; 20(1):207. PubMed ID: 32345243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shining the spotlight on cardioprotection: beyond the cardiomyocyte.
    Davidson SM; Andreadou I; Garcia-Dorado D; Hausenloy DJ
    Cardiovasc Res; 2019 Jun; 115(7):1115-1116. PubMed ID: 30865272
    [No Abstract]   [Full Text] [Related]  

  • 35. Morphine Analgesia Pre-PPCI Is Associated with Prothrombotic State, Reduced Spontaneous Reperfusion and Greater Infarct Size.
    Farag M; Spinthakis N; Srinivasan M; Sullivan K; Wellsted D; Gorog DA
    Thromb Haemost; 2018 Mar; 118(3):601-612. PubMed ID: 29444530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of intravenous fentanyl compared with morphine on ticagrelor absorption and platelet inhibition in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: rationale and design of the PERSEUS randomized trial.
    Degrauwe S; Roffi M; Lauriers N; Muller O; Masci PG; Valgimigli M; Iglesias JF
    Eur Heart J Cardiovasc Pharmacother; 2019 Jul; 5(3):158-163. PubMed ID: 30101278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism of interleukin-1 receptor antagonist protection against myocardial ischaemia/reperfusion-induced injury.
    Qian W; Zhao C; Li D; Dai R
    Arch Cardiovasc Dis; 2018 Oct; 111(10):545-554. PubMed ID: 29724623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remote ischaemic conditioning and healthcare system delay in patients with ST-segment elevation myocardial infarction.
    Pryds K; Terkelsen CJ; Sloth AD; Munk K; Nielsen SS; Schmidt MR; Bøtker HE;
    Heart; 2016 Jul; 102(13):1023-8. PubMed ID: 26911520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myocardial ischemia-reperfusion injury: a neglected therapeutic target.
    Hausenloy DJ; Yellon DM
    J Clin Invest; 2013 Jan; 123(1):92-100. PubMed ID: 23281415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preconditioning and postconditioning: underlying mechanisms and clinical application.
    Hausenloy DJ; Yellon DM
    Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.